Elsevier

The Lancet

Volume 346, Issue 8981, 14 October 1995, Pages 1004-1005
The Lancet

Short reports
Extrinsic-pathway activation in cancer with high factor Vlla and tissue factor

https://doi.org/10.1016/S0140-6736(95)91690-3Get rights and content

References (11)

There are more references available in the full text version of this article.

Cited by (218)

  • Tumor-educated platelets

    2024, Clinica Chimica Acta
  • Extracellular vesicles exposing tissue factor for the prediction of venous thromboembolism in patients with cancer: A prospective cohort study

    2018, Thrombosis Research
    Citation Excerpt :

    Tumor-derived EV exposing TF (EV-TF) have been proposed to contribute to cancer-associated VTE [6]. The transmembrane protein TF, which is the main initiator of the coagulation pathway, is overexpressed in various types of cancer and can promote tumor growth and metastasis [7–9]. When tumor cells release EV-TF into the blood, these TF-positive EVs can activate coagulation and predispose cancer patients to VTE.

View all citing articles on Scopus
View full text